Biotechnology
Company Overview of Archemix Corp.
Executive Profile
Andrew Ellington Ph.D.Scientific Adviser, Traitwise, Inc. |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 2 different industries. See Board Relationships |
| -- | -- |
Background
Andrew Ellington, Andy, Ph.D., serves as member of scientific advisory board of Archemix Corp. Dr. Ellington is currently an Associate Professor of Chemistry and Biochemistry at the University for Texas in Austin. Dr. Ellington received his B.S., Michigan State University, Ph.D. from Harvard for work in the molecular evolution of enzymes and completed his postdoctoral training as a fellow at Harvard Medical School in the laboratory of Dr. Jack Szostak. Working with Dr. ...
Corporate Headquarters148 Sidney StreetCambridge, Massachusetts 02139 United States Phone: 617-621-7700 Fax: 617-621-9300 Board Members MembershipsThere is no Board Members Memberships data available.EducationPhD Harvard University BS Michigan State University Post-Doctoral Training Harvard Medical School
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Archemix Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








